Understanding the Therapeutic Approaches for Neuroprotection.
Payal, N
Sharma, L
Sharma, A
Hobanii, YH
Hakami, MA
Ali, N
Rashid, S
Sachdeva, M
Gulati, M
Yadav, S
Chigurupati, S
Singh, A
Khan, H
Behl, T
- Publisher:
- Bentham Science Publishers
- Publication Type:
- Journal Article
- Citation:
- Curr Pharm Des, 2023, 29, (42), pp. 3368-3384
- Issue Date:
- 2023
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
22645173_14204912080005671.pdf | Published version | 13.76 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Payal, N | |
dc.contributor.author | Sharma, L | |
dc.contributor.author | Sharma, A | |
dc.contributor.author | Hobanii, YH | |
dc.contributor.author | Hakami, MA | |
dc.contributor.author | Ali, N | |
dc.contributor.author | Rashid, S | |
dc.contributor.author | Sachdeva, M | |
dc.contributor.author | Gulati, M | |
dc.contributor.author | Yadav, S | |
dc.contributor.author | Chigurupati, S | |
dc.contributor.author | Singh, A | |
dc.contributor.author | Khan, H | |
dc.contributor.author | Behl, T | |
dc.date.accessioned | 2024-05-30T22:40:16Z | |
dc.date.available | 2023-10-07 | |
dc.date.available | 2024-05-30T22:40:16Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Curr Pharm Des, 2023, 29, (42), pp. 3368-3384 | |
dc.identifier.issn | 1381-6128 | |
dc.identifier.issn | 1873-4286 | |
dc.identifier.uri | http://hdl.handle.net/10453/179360 | |
dc.description.abstract | The term "neurodegenerative disorders" refers to a group of illnesses in which deterioration of nerve structure and function is a prominent feature. Cognitive capacities such as memory and decision-making deteriorate as a result of neuronal damage. The primary difficulty that remains is safeguarding neurons since they do not proliferate or regenerate spontaneously and are therefore not substituted by the body after they have been damaged. Millions of individuals throughout the world suffer from neurodegenerative diseases. Various pathways lead to neurodegeneration, including endoplasmic reticulum stress, calcium ion overload, mitochondrial dysfunction, reactive oxygen species generation, and apoptosis. Although different treatments and therapies are available for neuroprotection after a brain injury or damage, the obstacles are inextricably connected. Several studies have revealed the pathogenic effects of hypothermia, different breathed gases, stem cell treatments, mitochondrial transplantation, multi-pharmacological therapy, and other therapies that have improved neurological recovery and survival outcomes after brain damage. The present review highlights the use of therapeutic approaches that can be targeted to develop and understand significant therapies for treating neurodegenerative diseases. | |
dc.format | ||
dc.language | eng | |
dc.publisher | Bentham Science Publishers | |
dc.relation.ispartof | Curr Pharm Des | |
dc.relation.isbasedon | 10.2174/0113816128275761231103102125 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 1115 Pharmacology and Pharmaceutical Sciences | |
dc.subject.classification | Medicinal & Biomolecular Chemistry | |
dc.subject.classification | 3214 Pharmacology and pharmaceutical sciences | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Neuroprotection | |
dc.subject.mesh | Mitochondria | |
dc.subject.mesh | Neurons | |
dc.subject.mesh | Neurodegenerative Diseases | |
dc.subject.mesh | Endoplasmic Reticulum Stress | |
dc.subject.mesh | Brain Injuries | |
dc.subject.mesh | Oxidative Stress | |
dc.subject.mesh | Neurons | |
dc.subject.mesh | Mitochondria | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Brain Injuries | |
dc.subject.mesh | Neurodegenerative Diseases | |
dc.subject.mesh | Oxidative Stress | |
dc.subject.mesh | Endoplasmic Reticulum Stress | |
dc.subject.mesh | Neuroprotection | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Neuroprotection | |
dc.subject.mesh | Mitochondria | |
dc.subject.mesh | Neurons | |
dc.subject.mesh | Neurodegenerative Diseases | |
dc.subject.mesh | Endoplasmic Reticulum Stress | |
dc.subject.mesh | Brain Injuries | |
dc.subject.mesh | Oxidative Stress | |
dc.title | Understanding the Therapeutic Approaches for Neuroprotection. | |
dc.type | Journal Article | |
utslib.citation.volume | 29 | |
utslib.location.activity | United Arab Emirates | |
utslib.for | 1115 Pharmacology and Pharmaceutical Sciences | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | University of Technology Sydney/Faculty of Health/Public Health | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2024-05-30T22:40:03Z | |
pubs.issue | 42 | |
pubs.publication-status | Published | |
pubs.volume | 29 | |
utslib.citation.issue | 42 |
Abstract:
The term "neurodegenerative disorders" refers to a group of illnesses in which deterioration of nerve structure and function is a prominent feature. Cognitive capacities such as memory and decision-making deteriorate as a result of neuronal damage. The primary difficulty that remains is safeguarding neurons since they do not proliferate or regenerate spontaneously and are therefore not substituted by the body after they have been damaged. Millions of individuals throughout the world suffer from neurodegenerative diseases. Various pathways lead to neurodegeneration, including endoplasmic reticulum stress, calcium ion overload, mitochondrial dysfunction, reactive oxygen species generation, and apoptosis. Although different treatments and therapies are available for neuroprotection after a brain injury or damage, the obstacles are inextricably connected. Several studies have revealed the pathogenic effects of hypothermia, different breathed gases, stem cell treatments, mitochondrial transplantation, multi-pharmacological therapy, and other therapies that have improved neurological recovery and survival outcomes after brain damage. The present review highlights the use of therapeutic approaches that can be targeted to develop and understand significant therapies for treating neurodegenerative diseases.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph